- Home
- STTK vs PWOD Comparison
STTK vs PWOD Comparison
Compare STTK & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- PWOD
- Stock Information
- Founded
- STTK 2016
- PWOD 1934
- Country
- STTK United States
- PWOD United States
- Employees
- STTK N/A
- PWOD N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- PWOD Major Banks
- Sector
- STTK Health Care
- PWOD Finance
- Exchange
- STTK Nasdaq
- PWOD Nasdaq
- Market Cap
- STTK 173.6M
- PWOD 173.1M
- IPO Year
- STTK 2020
- PWOD N/A
- Fundamental
- Price
- STTK $3.84
- PWOD $21.54
- Analyst Decision
- STTK Strong Buy
- PWOD
- Analyst Count
- STTK 3
- PWOD 0
- Target Price
- STTK $10.67
- PWOD N/A
- AVG Volume (30 Days)
- STTK 123.8K
- PWOD 12.5K
- Earning Date
- STTK 11-07-2024
- PWOD 10-23-2024
- Dividend Yield
- STTK N/A
- PWOD 5.97%
- EPS Growth
- STTK N/A
- PWOD N/A
- EPS
- STTK N/A
- PWOD 2.31
- Revenue
- STTK $4,123,999.00
- PWOD $64,822,000.00
- Revenue This Year
- STTK $164.45
- PWOD N/A
- Revenue Next Year
- STTK N/A
- PWOD N/A
- P/E Ratio
- STTK N/A
- PWOD $9.27
- Revenue Growth
- STTK 380.09
- PWOD N/A
- 52 Week Low
- STTK $1.33
- PWOD $17.01
- 52 Week High
- STTK $11.76
- PWOD $24.10
- Technical
- Relative Strength Index (RSI)
- STTK 53.41
- PWOD 45.38
- Support Level
- STTK $3.63
- PWOD $20.18
- Resistance Level
- STTK $3.94
- PWOD $21.73
- Average True Range (ATR)
- STTK 0.22
- PWOD 0.83
- MACD
- STTK 0.06
- PWOD -0.14
- Stochastic Oscillator
- STTK 64.91
- PWOD 34.09
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.